NCT07254858 2025-11-28CISN-LFirst Affiliated Hospital of Wenzhou Medical UniversityPhase 2 Not yet recruiting302 enrolled
NCT06308939 2024-03-13Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical TrialZhejiang Cancer HospitalPhase 2 Not yet recruiting81 enrolled